140 results
Page 2 of 7
8-K
EX-10.4
6ozzk8c44j4y
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
twp6gkicyr12ar p2
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-4.2
lj8 c8lbi2ur
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
asrsvc2fj dnsxdar78
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.3
vhdl68y1252pss84bt1i
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
8z78h
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-4.1
186cpplx
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
j0s5p21n4aoxr
28 Dec 23
Other Events
4:14pm
8-K
EX-99.1
4tlt32knp2izixx
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm
8-K
EX-99.1
yglxn
14 Nov 23
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
4:36pm
8-K
EX-10.7.3
by6fetog59
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-99.4
1rlh 8y7bk
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-99.1
icniz4j
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.6
hi1576j6zol
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.26
xn9ach37xg4jnki
5 Oct 23
Index to Financial Statements
5:12pm